Corvidia Therapeutics' Series B Round

Corvidia Therapeutics raised a round of funding on April 25, 2018.

Corvidia Therapeutics is a biotechnology company pioneering the next generation of cardiovascular therapies. Leveraging functional genomics, the company's founding team has decoded previously unrecogn…

Articles about Corvidia Therapeutics' Series B Round: